Back to List

Add Discussion

Refresh List

Filtered Users

Banned Users

My Alerts

My Profile

SYNDAX PHARMACEUTICALS INC (SNDX)

Syndax Pharmaceuticals Announcements And Discussion

- 12/11/2017 11:09
Arnu Gutierrez Total posts: 30 - Member since: 16/8/2015
Intraday Stock Chart: Syndax Pharmaceuticals, Inc. (MM)Long Term Chart: Syndax Pharmaceuticals, Inc. (MM)
Intraday Stock ChartLong Term Chart

Syndax Pharmaceuticals Announcements And Discussion



List of comments
1 Comments
1
1 of 1 - 12/11/2017 11:12
Arnu Gutierrez Total posts: 30 - Member since: 16/8/2015
Syndax Pharmaceuticals reveals findings from early-stage study evaluating its entinostat plus Merck's KEYTRUDA in both PD-(L)1 refractory and PD-(L)1 naïve non-small cell lung cancer patients
http://crweworld.com/article/news-provided-by-pr-newswire/175569
1 Comments
1
Posts to follow: (1)
Last post time: 12/Nov/2017 00:12

Discussed Stocks
SNDX 8.81 3.2%
Syndax Pharmaceuticals, Inc. (MM)
Syndax Pharmaceuticals, Inc. (MM)
Syndax Pharmaceuticals, Inc. (MM)
World Indices
Australia -0.1%
Brazil 1.3%
Canada 0.0%
France 0.0%
Germany 0.0%
Greece 0.0%
Holland 0.0%
India (Bombay) 0.0%
Italy 0.0%
Japan (NIKKEI) -0.5%
Poland 1.3%
Portugal 0.0%
US (DowJones) -0.4%
US (NASDAQ) -0.2%
United Kingdom -0.1%
Gainers (%)
BXG 13.00 30.5%
FL 40.82 28.2%
ANF 15.54 23.8%
NGVC 6.25 17.9%
ANW 3.78 16.2%
KEG 10.12 15.1%
IO 14.70 14.4%
GCO 29.55 13.9%
LXFT 53.30 13.5%
GLOB 40.57 13.3%
Your Recent History
FX
EURAUD
Euro vs Au..
FX
USDAUD
US Dollar ..
ASX
WPL
Woodside
NASDAQ
AAPL
Apple
ASX
BHP
BHP Bilito..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20171120 06:06:30